McKelligon Brian 4
4 · Akoya Biosciences, Inc. · Filed Nov 21, 2024
Insider Transaction Report
Form 4
McKelligon Brian
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-11-19+218,750→ 443,483 total
Footnotes (2)
- [F1]The restricted stock units shall vest as to 50% on the first anniversary of the first day of the month subsequent to the date of grant (the "First Vesting Date") with the remainder vesting as follows: 25% on the date that is three months following the First Vesting Date; 25% on the date that is six months following the First Vesting Date; 25% on the date that is nine months following the First Vesting Date; and 25% on the date that is twelve months following the First Vesting Date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock.